Manufacturing Industry
Bioabsorble drug-eluting stent implanted in first human study.(MPMD)
Advanced Materials & Processes, July, 2006
Developed by Bioabsorbable Vascular Solutions, a Guidant subsidiary, the bioabsorbable everolimus-eluting stent is designed to be fully absorbed by vascular tissue following the restoration of blood flow in patients with coronary artery disease. The trial in Auckland City Hospital in New Zealand will evaluate the safety of the stent for treating heart disease.
- Most Popular Articles in Business
- Research and Markets : Tesco Plc - SWOT Framework Analysis
- Do Us a Flavor - Ben & Jerry's Issues a Call for Euphoric New Flavors
- eBay made easy: ready to start an eBay business? These 5 simple steps will ...
- Katrina's lawsuit surge: a legal battle to force insurers to pay for flood ...
- Wal-Mart's newest distribution center opened last month near the southwest ...
- More »
Unlike metallic stents, bioabsorbable stents ...
Read the rest of this article with a Free Trial at HighBeam Research.